Curable compositions and membranes

US9309343B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9309343-B2
Application numberUS-201214233167-A
CountryUS
Kind codeB2
Filing dateJul 5, 2012
Priority dateJul 19, 2011
Publication dateApr 12, 2016
Grant dateApr 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A membrane obtainable from curing a composition comprising (i) a curable compound comprising at least two acrylic groups and a quaternary ammonium group; (ii) solvent; and optionally (iii) a curable compound having one ethylenically unsaturated group.

First claim

Opening claim text (preview).

The invention claimed is: 1. A membrane obtained from curing a composition comprising: (i) a curable compound comprising (a) at least two acrylamide groups; and (b) at least one quaternary ammonium group; (ii) solvent; and optionally (iii) a curable compound having one ethylenically unsaturated group. 2. The membrane according to claim 1 wherein the composition further comprises a radical initiator. 3. The membrane according to claim 1 wherein optional component (iii) is present. 4. The membrane according to claim 1 wherein component (ii) comprises water or a mixture comprising water and a water-miscible organic solvent. 5. The membrane according to claim 1 wherein the curable compound having one ethylenically unsaturated group further comprises a cationic group. 6. The membrane according to claim 1 wherein component (i) comprises a compound of the Formula (1): wherein: R 1 and R 2 are H; R 3 and R 4 are each independently H or alkyl, or R 3 and R 4 together with the N atoms to which they are attached and Y form an optionally substituted 6- or 7-membered ring; and Y is a linking group comprising an optionally substituted and optionally interrupted alkylene or arylene group; provided that the compound of Formula (1) has at least one of 1, 2, 3 or 4 quaternary ammonium groups, wherein the at least one of 1, 2, 3 or 4 quaternary ammonium groups may be present as substituents and/or interruptions within the Y group or on the 6- or 7-membered ring formed by R 3 and R 4 together with the N atoms to which they are attached. 7. The membrane according to claim 1 comprising a structural unit of Formula (1′): wherein: R 1 and R 2 are H; R 3 and R 4 are each independently H or alkyl, or R 3 and R 4 together with the N atoms to which they are attached and Y form an optionally substituted 6- or 7-membered ring; and Y is a linking group comprising an optionally substituted and optionally interrupted alkylene or arylene group; provided that the structural unit of Formula (1′) has at least one of 1, 2, 3 or 4 quaternary ammonium groups, wherein the at least one of 1, 2, 3 or 4 quaternary ammonium groups may be present as substituents and/or interruptions within the Y group or on the 6- or 7-membered ring formed by R 3 and R 4 together with the N atoms to which they are attached. 8. The membrane according to claim 1 wherein the composition further comprises a radical initiator, component (ii) comprises water or a mixture comprising water and a water-miscible organic solvent and optional component (iii) is present and further comprises a cationic group. 9. The membrane according to claim 1 wherein the molar fraction of curable compounds comprising at least two acrylamide groups and a quaternary ammonium group, relative to the total number of moles of curable compounds present in the composition, is at least 0.30. 10. The membrane according to claim 1 wherein the composition comprises: (i) a curable compound comprising (a) at least two acrylamide groups; and (b) at least one quaternary ammonium group; (ii) a solvent; (iii) a curable compound having one ethylenically unsaturated group; (iv) a curable compound comprising at least two acrylamide groups and being free from quaternary ammonium groups; and (v) a radical initiator; and wherein the composition comprises: (a) 2 to 80 wt % of component (i), 15 to 70 wt % of component (ii), 1 to 70 wt % of component (iii), 0 to 40 wt % of component (iv); and 0 to 10 wt % of component (v); or (b) 5 to 80 wt % of component (i), 20 to 45 wt % of component (ii), 0 to 60 wt % of component (iii), 0 to 30 wt % of component (iv); and 0.1 to 10 wt % of component (v). 11. An electrodialysis or reverse electrodialysis unit, a flow through capacitor device, an electrodeionization module, a continuous electrodeionization module, a fuel cell, a diffusion dialysis apparatus, a membrane distillation module or a membrane electrode assembly comprising one or more polymeric membranes according to claim 1 . 12. An electrodialysis or reverse electrodialysis unit, a flow through capacitor device, an electrodeionization module, a continuous electrodeionization module, a fuel cell, a diffusion dialysis apparatus, a membrane distillation module or a membrane electrode assembly comprising one or more polymeric membranes according to claim 7 . 13. A process for preparing a membrane comprising the following steps: a) applying a composition to a support; and b) curing the composition to form a membrane; wherein the composition comprises (i) a curable compound comprising (a) at least two acrylamide groups; and (b) at least one quaternary ammonium group; (ii) solvent; and optionally (iii) a curable compound having one ethylenically unsaturated group; and wherein the curing is performed by radical polymerisation using electromagnetic radiation. 14. The process according to claim 13 wherein the composition comprises: (i) a curable compound comprising (a) at least two acrylamide groups; and (b) at least one quaternary ammonium group; (ii) a solvent; (iii) a curable compound having one ethylenically unsaturated group; (iv) a curable compound comprising at least two acrylamide groups and being free from quaternary ammonium groups; and (v) a radical initiator; and wherein the composition comprises: (a) 2 to 80 wt % of component (i), 15 to 70 wt % of component (ii), 1 to 70 wt % of component (iii), 0 to 40 wt % of component (iv); and 0 to 10 wt % of component (v); or (b) 5 to 80 wt % of component (i), 20 to 45 wt % of component (ii), 0 to 60 wt % of component (iii), 0 to 30 wt % of component (iv); and 0.1 to 10 wt % of component (v). 15. The process according to claim 14 wherein the curing is performed using electron beam or UV radiation. 16. The process according to claim 13 wherein the curing is performed using electron beam or UV radiation. 17. The process according to claim 13 wherein the composition is applied continuously to a moving support by means of a manufacturing unit comprising a composition application station, an irradiation source for curing the composition, a membrane collecting station and a means for moving the support from the composition application station to the irradiation source and to the membrane collecting station. 18. The process according to claim 17 wherein the curable composition is applied to the support moving at a speed of over 5 m/min.

Assignees

Inventors

Classifications

  • Homopolymers or copolymers of acrylamide or methacrylamide · CPC title

  • containing oxygen in addition to the carboxy oxygen {, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate} · CPC title

  • Polyamides, e.g. polyester-amides · CPC title

  • Fuel cells with polymeric electrolytes · CPC title

  • characterised by specific membranes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9309343B2 cover?
A membrane obtainable from curing a composition comprising (i) a curable compound comprising at least two acrylic groups and a quaternary ammonium group; (ii) solvent; and optionally (iii) a curable compound having one ethylenically unsaturated group.
Who is the assignee on this patent?
Van Berchum Bastiaan, Van Baak Willem Johannes, Hessing Jacko, and 1 more
What technology area does this patent fall under?
Primary CPC classification C08F222/385. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).